Randomised phase II trial comparing vinorelbine and capecitabine with docetaxel and capecitabine chemotherapy for metastatic breast cancer

Completed

• Conditions: Breast cancer; Cancer; Breast

• Registration Number: ISRCTN66842537
• Lead Sponsor: Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Metastatic breast cancer following initially histologically proven adenocarcinoma of the breast.

Exclusion Criteria

Exclusions include previous treatment with vinorelbine, docetaxel or capecitabine and presence of other primary cancers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Toxicity, response and survival.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration